Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Fibronectin (FN) is crucial in the tumor microenvironment, but its role in metastasis is not fully understood.
• Tumor cell-extracellular matrix (ECM) interactions are key drivers of directed tumor cell migration and metastasis.

Purpose of the Study:

• To elucidate the mechanism by which fibronectin gradients promote breast cancer cell metastasis.
• To identify the molecular players involved in fibronectin-guided cell migration and ECM remodeling.

Main Methods:

• In vitro and in vivo experiments assessing breast cancer cell migration on fibronectin gradients.
• Analysis of the interaction between α5β1 integrin, MENA, and its prometastatic isoform MENA(INV).
• Correlation of MENA(INV) and FN levels with clinical data from breast cancer cohorts.

Main Results:

• Fibronectin (FN) gradients induce directional migration (haptotaxis) of breast cancer cells.
• This migration requires α5β1 integrin interaction with the actin regulator MENA, enhancing focal complex signaling and ECM remodeling.
• The MENA(INV) isoform promotes 3D haptotaxis towards high FN concentrations, and its levels correlate with increased tumor recurrence and decreased patient survival.

Conclusions:

• A novel, tumor cell-intrinsic mechanism promotes metastasis through ECM remodeling and FN-guided migration.
• The interaction between α5β1 integrin, MENA, and FN is critical for directed cell movement in the tumor microenvironment.
• MENA(INV) is identified as a key player in promoting breast cancer metastasis and is associated with poor patient outcomes.